VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One. 2012; 7(4):e34833.
View in:
PubMed
subject areas
Apoptosis
Dose-Response Relationship, Drug
Fatty Acids, Monounsaturated
Gene Expression Profiling
Gene Transfer Techniques
Genetic Therapy
Humans
Lung Neoplasms
Maximum Tolerated Dose
Nanoparticles
Plasmids
Positron-Emission Tomography
Quaternary Ammonium Compounds
Reverse Transcriptase Polymerase Chain Reaction
Tumor Suppressor Proteins
authors with profiles
ELIZABETH A GRIMM
JACK A ROTH
JIUN-KAE JACK LEE
LIN JI
MARSHALL E HICKS
CHARLES LU
JEREMY J ERASMUS
IGNACIO IVAN WISTUBA
VEERABHADRAN BALADANDAYUTHAPANI
MARIA NUNEZ